Epidemiologist
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Jamal T. Jones, PhD, MPH is an epidemiologist on the Sentinel Core Team within FDA’s Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology. In this role, Dr. Jones provides scientific oversight and review of Sentinel modular program reports, pharmacoepidemiologic study protocols, web pages dedicated to individual medical product analyses and overarching medical product study pages, and other documents related to the implementation and execution of the Sentinel Initiative. Dr. Jones is tasked with guiding project direction to meet FDA needs for Sentinel studies and communicating with key stakeholders. Dr. Jones primarily conducts studies on medical product utilization and to characterize various data elements in the Sentinel Distributed Database as well as electronic health record data aggregators. Dr. Jones is also involved in studies utilizing Sentinel analytic tools for safety signal identification and evaluation. Prior to joining the Sentinel Core Team, Dr. Jones served as an epidemiologist at FDA’s Center for Tobacco Products where he performed scientific review of premarket tobacco product applications and conducted studies assessing tobacco product use behaviors and smoking cessation. He previously conducted health services research to prevent HIV among persons with increased risk for HIV acquisition – with an emphasis on HIV pre-exposure prophylaxis uptake in the United States – at the Centers for Disease Control and Prevention.